Middle East Healthcare Company (TADAWUL: 4009)
Saudi Arabia
· Delayed Price · Currency is SAR 69.00
+1.00 (1.47%)
Nov 20, 2024, 3:15 PM AST
Middle East Healthcare Company Income Statement
Financials in millions SAR. Fiscal year is January - December.
Millions SAR. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Revenue | 2,854 | 2,653 | 2,152 | 1,873 | 1,751 | 1,497 | Upgrade
|
| Revenue Growth (YoY) | 11.85% | 23.30% | 14.91% | 6.97% | 16.97% | 7.62% | Upgrade
|
| Cost of Revenue | 1,739 | 1,649 | 1,480 | 1,277 | 1,189 | 1,034 | Upgrade
|
| Gross Profit | 1,115 | 1,004 | 671.99 | 595.14 | 561.78 | 462.82 | Upgrade
|
| Selling, General & Admin | 688.71 | 661.23 | 531.65 | 540.9 | 454.37 | 359.56 | Upgrade
|
| Operating Expenses | 688.71 | 661.23 | 531.65 | 540.9 | 454.37 | 359.56 | Upgrade
|
| Operating Income | 426.4 | 342.5 | 140.34 | 54.24 | 107.41 | 103.27 | Upgrade
|
| Interest Expense | -224.44 | -153.18 | -69.01 | -41.52 | -31.11 | -20.02 | Upgrade
|
| Other Non Operating Income (Expenses) | 39.72 | 13.05 | 11.87 | 8.19 | 6.06 | 11.82 | Upgrade
|
| EBT Excluding Unusual Items | 241.68 | 202.37 | 83.2 | 20.91 | 82.35 | 95.07 | Upgrade
|
| Gain (Loss) on Sale of Assets | -0.76 | -0.76 | -1.98 | -1.68 | -1.67 | 0.22 | Upgrade
|
| Pretax Income | 240.92 | 201.62 | 81.22 | 19.23 | 80.69 | 95.28 | Upgrade
|
| Income Tax Expense | 29.4 | 17.98 | 9.62 | 7.5 | 5.5 | 5.18 | Upgrade
|
| Earnings From Continuing Operations | 211.52 | 183.63 | 71.6 | 11.73 | 75.19 | 90.11 | Upgrade
|
| Minority Interest in Earnings | -0.16 | -3.46 | 3.58 | 5.47 | 6.81 | 7.46 | Upgrade
|
| Net Income | 211.36 | 180.18 | 75.18 | 17.2 | 81.99 | 97.57 | Upgrade
|
| Net Income to Common | 211.36 | 180.18 | 75.18 | 17.2 | 81.99 | 97.57 | Upgrade
|
| Net Income Growth | 19.52% | 139.65% | 337.08% | -79.02% | -15.96% | -43.36% | Upgrade
|
| Shares Outstanding (Basic) | 92 | 92 | 92 | 92 | 92 | 92 | Upgrade
|
| Shares Outstanding (Diluted) | 92 | 92 | 92 | 92 | 92 | 92 | Upgrade
|
| EPS (Basic) | 2.30 | 1.96 | 0.82 | 0.19 | 0.89 | 1.06 | Upgrade
|
| EPS (Diluted) | 2.30 | 1.96 | 0.82 | 0.19 | 0.89 | 1.06 | Upgrade
|
| EPS Growth | 19.52% | 139.65% | 337.08% | -79.02% | -15.96% | -43.36% | Upgrade
|
| Free Cash Flow | 205.55 | -38.53 | -173.5 | -339.94 | -522.22 | -372.68 | Upgrade
|
| Free Cash Flow Per Share | 2.23 | -0.42 | -1.89 | -3.69 | -5.67 | -4.05 | Upgrade
|
| Gross Margin | 39.07% | 37.83% | 31.23% | 31.78% | 32.09% | 30.92% | Upgrade
|
| Operating Margin | 14.94% | 12.91% | 6.52% | 2.90% | 6.14% | 6.90% | Upgrade
|
| Profit Margin | 7.41% | 6.79% | 3.49% | 0.92% | 4.68% | 6.52% | Upgrade
|
| Free Cash Flow Margin | 7.20% | -1.45% | -8.06% | -18.15% | -29.83% | -24.90% | Upgrade
|
| EBITDA | 614.61 | 516.23 | 269.9 | 185.15 | 228.42 | 197.04 | Upgrade
|
| EBITDA Margin | 21.54% | 19.46% | 12.54% | 9.89% | 13.05% | 13.17% | Upgrade
|
| D&A For EBITDA | 188.21 | 173.73 | 129.56 | 130.91 | 121.01 | 93.77 | Upgrade
|
| EBIT | 426.4 | 342.5 | 140.34 | 54.24 | 107.41 | 103.27 | Upgrade
|
| EBIT Margin | 14.94% | 12.91% | 6.52% | 2.90% | 6.14% | 6.90% | Upgrade
|
| Effective Tax Rate | 12.20% | 8.92% | 11.84% | 39.00% | 6.82% | 5.43% | Upgrade
|
| Advertising Expenses | - | 9.74 | 7.59 | 7.13 | 3.78 | 3.49 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.